Terry Klassen retweeted
…both!
PRoMPT BOLUS found:
• 0.9% saline AND balanced fluids are safe & effective in suspected pediatric septic shock
• Fluid type does NOT impact major outcomes (mortality, kidney injury)
• Biochemical differences ≠ differences in patient-centered outcomes
@PERC_network @PREDICT_network
nejm.org/doi/full/10.1056/NE…
Terry Klassen retweeted
🚨 Hot off the press! 🚨
Introducing the PRoMPT BOLUS study results — a landmark trial evaluating the safety & efficacy of normal saline vs. balanced fluids in suspected pediatric septic shock
🌍 9,000+ children
🏥 47 sites
🌎 5 countries
And the winner is… 👇
nejm.org/doi/full/10.1056/NE…
@nkuppermann @franbalamuth
Terry Klassen retweeted
Congratulations to Liz Sellers and @bwicklow1 @DREAM_diabetes for @CIHR_IRSC funding for "Co-designing enhanced models of care for First Nations Children at risk for childhood-onset type 2 #diabetes: The Next Generation Birth Cohort"! 👏 Read more: chrim.ca/2026/2025-fall-proj…
Terry Klassen retweeted
#USask's Dr. Terry Klassen (MD) is part of a cross-Canadian study evaluating the best pain medicines for treating kids with broken bones and sprains.
medicine.usask.ca/news/2026/…
@UAlberta_FoMD
Terry Klassen retweeted
Bayesian statistics for clinical research
This review provides a brief account of the philosophical and methodological differences between Bayesian and frequentist approaches and survey the use of Bayesian methods for the design and analysis of clinical research.
#Bayesian #bayestheorem #ClinicalTrial #Probabilities
thelancet.com/journals/lance…
Terry Klassen retweeted
Ondansetron is often prescribed at ED discharge for children seen for gastroenteritis to reduce further symptoms, but evidence to support doing so is limited. A new trial investigates whether postdischarge ondansetron is beneficial. Full trial results: nej.md/3GIJfI7
Multidose Ondansetron after Emergency Visits in Children with Gastroenteritis | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
Terry Klassen retweeted
Great to host this amazing @PedChairsCan team @SickKidsNews !!
Terry Klassen retweeted
CHRIM summer student, Evan Abram and the REACH theme, have released a new publication titled "Improving patient care experience in the pediatric emergency department: a systematic review". Read it here: link.springer.com/article/10…
Terry Klassen retweeted
Today is #RareDiseaseDay.
#USaskMed’s Daislyn Vidal joined CBC Saskatoon Morning with @YXEStephanie to talk about rare diseases and the important work of @RareKidsCAN.
Listen now: ow.ly/YbRa50V8BIE
Ottawa signs $40M deal with Saskatchewan to offer drug coverage for rare diseases | Globalnews.ca globalnews.ca/news/10953389/…
A beautiful venue for Pediatric Research day at Queen’s University. I made the case that RCTs are still an essential tool in child health to reduce uncertainty around decisions in health care. @MCSamaan1 @bob_connelly
I am sure you will do great things for child health at @ChildrensNatl
Excited to start today as EVP, Chief Acad Officer, Chair of Pediatrics @ChildrensNatl working with an outstanding team under the leadership of a great @ChildrensNatCEO Michelle Riley-Brown; and so proud of @UCDavisEM and my ongoing collaborations there. @PECARNteam
Terry Klassen retweeted
Earlier today, the SHA & @SKGov announced the recruitment of pediatric gastroenterologist Dr. Rabin Persad, who will begin practicing in #Sask in Oct. This is the next step in the expansion of a provincial pediatric gastroenterology prgm. More: saskatchewan.ca/government/n…
Terry Klassen retweeted
CBC spoke with Dr. Sarah Forgie, the new dean of the #USask College of Medicine.
Dr. Forgie is the first woman to be the full dean of the college: cbc.ca/listen/live-radio/1-8…
I feel so fortunate to have Dr Sarah Forgie as my dean. I feel very optimistic about our future here at USask.
Welcome to Dr. Sarah Forgie, the new #USask Dean of Medicine! A pediatrician, scholar, and esteemed educator, Dean Forgie officially began her five-year term on July 1 and is the first woman to be the full dean of the college. ow.ly/pNCu50Sy4ar





















